The formation of blood cells is an enormously complex process that involves the interactions of a large number of growth regulatory proteins with pluripotential hematopoietic stem and progenitor cells in the bone marrow cavity. Evidence suggests that a group of supporting cells making up the microenvironment surrounding these hematopoietic cells [termed the hematopoietic microenvironment (HM)] are important for sustained hematopoiesis both in vivo and in vitro (1) . The HM is made up of multiple cell types of several lineages, many derived from nonhematopoietic cells, arranged in a complex interactive nature in the medullary cavity (2) . Direct interactions between these cell types and hematopoietic stem and progenitor cells have been termed a "local area network" or LAN to emphasize multiple interactions among different cells locally (3) .
Our approach to the study of this complex interactive network has been to use recombinant retroviral vectors to efficiently transfer and express immortalizing mammalian oncogenes in these cells. One useful retroviral vector, termed U19-5, was described in 1987 by Jat and Sharp (4) and contains the simian virus 40 large T (LT) antigen (Fig. 1) . Expression of LT using this vector has led to the generation of a number of permanent cell lines derived from the medullary cavity of mice (5), primates (6) , and humans (7), as well as the HM of murine fetal liver (8) and yolk sac blood islands (9) . Such clonal cell lines have been used to study a number of aspects of the HM, including cell-cell interactions (lo), adhesive proteins responsible for stem cell localization in the HM (ll), and growth factor production by these cells (12) .
Multiple immortalized stromal cell lines derived from HM of nonhuman primates have been generated and studied in detail. One such cell line, designated PU-34, was noted to support the survival or proliferation of megakaryocytes from human bone marrow stem/ progenitor cells in vitro (6) . This cell line was extensively examined for the production of known hematopoietic growth factors, as well as for the production of growth stimulatory activities that could not be explained on the basis of known growth factors (12) . Conditioned medium from this cell line stimulated the proliferation of a murine plasmacytoma cell line, T1165, which was known to be responsive on IL-6. Although PU-34 expressed IL-6 as determined by Northern blot analysis of total RNA, addition of saturating amounts of neutralizing antibody to IL-6 failed to completely inhibit PU-34 CM stimulation of TI165 cells. This residual bioactivity was the basis of the cloning of a novel factor, termed IL-11, from a PU-34 cDNA library using expression cloning methods (12) . Our laboratory and a number of investigators have demonstrated that IL-11 stimulates the growth of megakaryocyte colonies in vitro when used with other growth factors, particularly IL-3 (Table 1) . IL-11 has stimulatory effects on a variety of hematopoietic stem and progenitor cell populations in vitro, and these effects have recently been reviewed in depth (13) . IL-11 has also been shown to have effects on several nonhematopoietic cell types in in vitro culture systems, including preadipocyte cells (14) , hippocampal cell lines (15) , synoviocytes (16) , and hepatocytes (17, 18) . These studies suggest that IL-11 has pleiotropic effects on a variety of cells types and that the effects of IL-11 in vivo may not be easily predicted from in vitro studies. Extensive preclinical testing of the effects of IL-11 in vivo has been carried out in rodent models in our laboratory. Treatment of mice undergoing bone marrow transplantation was first examined (19) . Mice receiving 12.5 Gy of total body irradiation and syngeneic bone marrow infusions develop marrow hypoplasia and peripheral cytopenias in the first 3 wk after irradiation. Treatment of these animals with IL-11 shortens the period of thrombocytopenia (Fig. 2) , and the increase in peripheral platelet counts is dose dependent. Surprisingly, IL-11 treatment also significantly reduced the period of posttransplantation neutropenia in this model (Fig. 3) . Examination of the bone marrow of these mice demonstrates that IL-11-treated mice have a large increase in the number of megakaryoctyes and megakaryocyte progenitor cells, as well as significantly increased bone marrow cellularity. Myeloid lineage-restricted and multilineage progenitor cells were also increased compared with those in control mice. Increased platelet counts in mice treated with IL-11 have been noted by other investigators in every rodent model examined (20) (21) (22) (23) , although the effects of IL-11 on other blood lineages is variable and appears to depend on the method of cytoablation used (13) . Additional preclinical testing in another animal model (Fig. 4) has revealed an unexpected and unique effect of IL-11 on small-intestine villi. Combining chemotherapy (5-fluorouracil) and sublethal total body irradiation (6 Gy) treatments in mice leads to significant mortality, apparently due to destruction of the small-intestine villus structures. The mucosal lining of the gastrointestinal tract is an important barrier to the entry of bacteria into the bloodstream and is frequently adversely affected by chemotherapy or radiation (24). In the model described above, the high mortality of treated mice was associated with widespread bacterial foci throughout the mice that contained Escherichia coli by bacteriologic analysis. Examination of the small intestine of these animals revealed extensive shortening of the villus structure and destruction of the normal architecture of the small bowel (25) . Treatment of mice given combined chemotherapy and radiation with IL-11 was associated with a significant increase in survival (Fig. 5) . Morphometric analysis of the small-intestine villi of these mice revealed a significant increase in the length of the villi compared with control mice (Table 2 ). In addition, staining of the smallintestine sections with an MAb to proliferating cell nuclear antigen (a member of the cyclin family) revealed increased nuclear staining in the crypt structures near the location of the crypt stem cell ( Table 3 ). These data suggest that IL-11 directly or indirectly stimulates the proliferation of small-intestinal crypt progenitorlstem cell populations and is associated with improved recovery of small-intestine villi after damaging chemotherapy or irradiation, The physiologic role(s) of IL-11 remains unclear. Several approaches are currently under way to determine the normal function of IL-11 in murine hematopoiesis. Expression analysis by RNA analysis of tissues and in situ hybridization should elucidate the tissues and cells expressing IL-11 in both normal mice and mice under hematopoietic stress. In addition, using gene-targeting methods (26) , null mutations can be introduced into the murine IL-11 genomic sequence by homologous recombination technology. Subsequent generation of homozygous deficient mice using embryonic stem cells and embryo transfer should provide clues to the function of IL-11 in normal biology.
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Regardless of the physiologic role of IL-11, it is clear that this cytokine may prove useful in treating cytopenias, especially thrombocytopenia, secondary to cancer therapies (27, 28) to excellence in clinical care in the Pediatric Hematology1 the laboratory to flourish. I have been generously sup-
